# Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors

> **NCT01944046** · PHASE2 · COMPLETED · sponsor: **Linmarie Sikich** · enrollment: 290 (actual)

## Conditions studied

- Autism Spectrum Disorders

## Interventions

- **DRUG:** Double blind phase Placebo Nasal Spray
- **DRUG:** double Blind Oxytocin Nasal Spray
- **DRUG:** Open Label intranasal oxytocin

## Key facts

- **NCT ID:** NCT01944046
- **Lead sponsor:** Linmarie Sikich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-01
- **Primary completion:** 2017-11-30
- **Final completion:** 2017-11-30
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2021-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01944046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01944046, "Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01944046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*